aptar pharma landmark dose indicator chosen for new asthma combination therapy

asthma dispensers, puffs and others for essay use.

Company Name: 
aptargroup sa
Contact Person: 
executive technical

&bullaptar pharma, a world leader in the development and manufacturing of nasal and pulmonary drug delivery devices has developed a unique customized dose indicator for flutiform ® . flutiform ® , a skyepharma product, is licensed to mundipharma international corporation limited in europe.&bullflutiform®  is indicated for the maintenance treatment of asthma in patients aged 12 years and over 505µg and 1255µg strengths and in adults 25010µg strength.&bullkey benefits flutiform®  is a combination of fluticasone and formoterol in a pressurized metered dose inhaler pmdi, dose indicator technology and incorporates a customized metering valve derived from aptar pharma&rsquos df30 technology platform.   

Privacy Policy